March 17, 2021 This week, we’ve seen startup funding going into businesses at every end of the spectrum — from early-stage and up-an-coming players to global behemoths landing valuations of $100 billion-plus. QBiotics Aussie biotech QBiotics is making headway in the fight against cancer, with their product already working on canines — so now they’re working on getting it approved for people as well as pups. The company secured $50 million to fund clinical trials for its cancer therapy treatment. Co-founded by former CSIRO scientists Dr Victoria Gordon and Dr Paul Reddell, the 21-year-old business has reportedly brought TDM Growth Partners on board as its first institutional investor.